Posted in | News | Nanobusiness

Russian Corporation of Nanotechnologies Concludes Memorandum of Cooperation

Eurasian Development Bank and state corporation Russian Corporation of Nanotechnologies, RUSNANO, recently concluded a memorandum of cooperation. Signing the memorandum on behalf of their respective organizations were Chairman of the Executive Board of the EDB Igor Finogenov and RUSNANO CEO Anatoly Chubais.

The parties agreed to coordinate their efforts in accomplishing mid-sized and long-term investment projects to strengthen integration of economic processes among countries of the Eurasian Economic Community as well as to increase their production of innovative nanotech-enabled goods with high benefit and create new workplaces in industry, medicine, transportation, and other areas of commerce in EurAsEC countries.

Among plans envisioned are that the EDB would finance projects by extending loans, including structured credit of $30 million to $100 million for up to ten years and participate in the charter capital of RUSNANO’s project companies that aim at developing integration processes, especially between the countries of EDB activity. Eligible projects would encourage the growth of innovation economies on the territory of the EurAsEC, promote trade among EurAsEC countries, and be realized with the participation of shareholders' capital of legal entities organized in countries of the Eurasian Economic Community.

The memorandum opens the door for the Eurasian Development Bank to take part in the innovation funds that are established with RUSNANO’s involvement. RUSNANO, for its part, has expressed interest in nanotechnology projects being carried out by clients of the Eurasian Development Bank. RUSNANO may finance, take an equity position, or extend guarantees to such projects.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.